Stem Cell News: Breaking Stem Cell News, Comments and Articles. - Page: 5

Citicoline Supplementation May Significantly Slow Glaucoma Progression

New Italian study found 500mg dose of Kyowa’s Citicoline may improve eye health. (PRWEB) May 16, 2013 Citicoline is well known as a powerful brain health nutrient, and now is being counted as a supplement that may significantly slow the progression of visual acuity loss due to glaucoma. Researchers at the Sao Paolo Hospital Eye Clinic at the University of Milan followed 41 patients with progres...

Cellectis: TAL-effector nuclease: Issuance by the USPTO of Two New Patents

Cellectis provides its customers TALENTM product under license of these patents to easily achieve any genome engineering projects. Regulatory News: Cellectis (Paris:ALCLS) (NYSE PA: ALCLS), the global genome engineering specialist, announced the issuance by the USPTO on May 14th, 2013 of two new US patents (US 8,440,431 and US 8,440,432...

Brain makes call on which ear is used for cell phone

If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.

Download: Presentation by Geoff MacKay of Organogenesis on the path to allogeneic cell therapy approval

Geoff MacKay, CEO of Organogenesis, spoke at last year’s Stem Cells & Regenerative Medicine Congress, on the topic ‘The path to a CBER FDA allogeneic [...]

Risky Squamous Cell Skin Cancers Can Kill (CME/CE)

(MedPage Today) -- Most cutaneous squamous cell carcinomas are easily treated surgically, but patients with specific disease risk factors develop metastases and ultimately die of the disease, a retrospective study determined.

International Stem Cell (OTC: ISCO) – HOLD – going where, when and how?

              Net loss was $1.7 M or $0.02 per share     Net loss was $1.7 M or $0.02 per share, compared to $4.13 M or $0.05 per share for Q1/12 Revenue was $1.3 M compared with $1 M in Q1/12, an increase of 19%.  Sales for Lifelin...

The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA

Summit features an expanded roster of meetings with increased formulation foci plus new meetings delving into early IND strategies and biomanufacturing. Needham, Mass. (PRWEB) May 16, 2013 Cambridge Healthtech Institute will host its fifth annual The Bioprocessing Summit from August 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, MA. The ten meetings comprising the Summit provide a cl...

X-ray Tomography on a Living Frog Embryo

Classical X-ray radiographs provide information about internal, absorptive structures of organisms such as bones. Alternatively, X-rays can also image soft tissues throughout early embryonic...

Natural Killer cells activate hematopoiesis

Infections can trigger hematopoiesis at sites outside the bone marrow – in the liver, the spleen or the skin. LMU researchers now show that a specific type of immune cell facilitates such “extra...

Stem Cell Action Coalition Applauds Cloned Stem Cell Breakthrough

The Stem Cell Action Coalition, a network of 75 nonprofit disease advocacy groups, scientific societies and academic centers, applauds the researchers at the Oregon Health and Science University for their groundbreaking accomplishment of producing stem cells utilizing the process of somatic cell nuclear transfer (SCNT). “The creation of c...

Biogen Idec Foundation Awards $250,000 to East End House to Develop Genetics Education Program

– GenoExplorers Seeks to Introduce Middle School Students to Genetics Concepts Through Interactive Learning – Today the Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement and evaluate an interactive out-of-school-time (OST) genetics program for middle school youth in Cambridge.

Controversy Lurks As Cloning Technique Yields Embryos With Eye On Stem Cell Therapies

Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's. Los Angeles Times: For First Time, Stem Cells Are Produced From Cloning Technique For the first time, scientists have created human embryos that are genetic copies of living peop...

Controversy Lurks As Cloning Technique Yields Embryos For Use In Stem Cell Therapies

Political and ethical fights over human cloning may follow the latest stem cell therapy advance after scientists created embryos that are genetic copies of living people in an effort to treat diseases such as Alzheimer's. Los Angeles Times: For First Time, Stem Cells Are Produced From Cloning Technique For the first time, scientists have created human embryos that are genetic copies of living peop...

Viewpoints: When A Doctor Should Keep Quiet; 2 Views Of Hospital Pricing; Stem Cell 'Snake Oil'

Los Angeles Times: For A Dying Patient, A Prescription Of Silence In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions. And with patients likely to die of their diseases, discussing the prognosis frankly would allow them...

Question Over Value of Routine CT Scans in Lymphoma

Patients with diffuse large B cell lymphoma are monitored with CT, but should they be? They detect relapses in only a handful of patients. Medscape Medical News

Bacterin Receives Compliance Notice from NYSE MKT

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it has received a compliance notice from the NYSE MKT compliance group. Specifically the notice indicated that the Company is not in compliance with Sections 1003(a)(ii...

Chronix Biomedical Announces Multiple Poster Presentations at ASCO 2013

Data Highlight Next-Generation Sequencing of Cell-Free DNA to Detect Minimal Residual Disease in a Variety of Cancers Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, announces that four research abstracts highlighting the Company’s cell-free DNA technology for real-time cancer detection will be presented at the American So...

New Stem Cell Growth Strategy Could Yield Better Way to Treat Brain Lesions

In a study just published in STEM CELLS Translational Medicine, researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer. Durham...

ACT Confirms Clinical Trial Participant Showed Improvement in Vision from 20/400 to 20/40 Following Treatment

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation of the company’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has improved from 20/400 to 20/40 following treatment. The improv...

Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), announced detailed results from the randomized Phase III START trial of its investigational MUC1 antigen-specific cancer immunotherapy L-BLP25 (formerly referred to as Stimuvax) in patients...

Fast and painless way to better mental arithmetic? Yes, there might actually be a way

In the future, if you want to improve your ability to manipulate numbers in your head, you might just plug yourself in. So say researchers who report in the Cell Press journal Current Biology on May 16 on studies of a harmless form of brain stimulati...

Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference

NEW YORK, May 16, 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCBB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for treatment of advanced cancers, announced that the official program of TAT: Target Alpha Therapy (TAT) international symposium will feature a presentation devoted to Actinium Pharmaceuticals' clinical programs.  T...

FDA approves erlotinib with EGFR mutation test for advanced NSCLC

The U. S. Food and Drug Administration approved erlotinib (Tarceva, Astellas Pharma Inc.) for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) patients whose tumours have epidermal growth factor receptor (EGFR) exon 19 deleti...

Researchers Successfully Convert Human Skin Cells Into Embryonic Stem Cells

[WATCH VIDEO: Contracting Cardiomyocystes] redOrbit Staff & Wire Reports - Your Universe Online Researchers at Oregon Health & Science University (OSHU) and the Oregon National Primate Research Center (ONPRC) have successfully reprogrammed human skin cells to become embryonic stem cells capable of transforming into any other cell type in the body, a breakthrough that marks the first tim...

First Edition: May 16, 2013

Today's headlines detail the Senate confirmation of Acting Chief Marilyn Tavenner to run the Centers for Medicare & Medicaid Services.   Kaiser Health News: Senate Confirms Tavenner To Head CMS Kaiser Health News' Mary Agnes Carey talks with Jennifer Haberkorn of Politico Pro about the Senate's confirmation Wednesday of Marilyn Tavenner to head the Centers for Medicare...